Limaiem F, Mlika M, Ovarian Cystadenoma. [Updated 2023 Jun 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536950/

Tjokroprawiro BA, Novitasari K, Ulhaq RA, Sulistya HA. Clinicopathological analysis of giant ovarian tumors. Eur J Obstet Gynecol Reprod Biol X. 2024;22:100318. https://doi.org/10.1016/j.eurox.2024.100318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carbonnel M, Layoun L, Poulain M, Tourne M, Murtada R, Grynberg M, Feki A, Ayoubi JM. Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women. J Clin Med. 2021;10(18):4233. https://doi.org/10.3390/jcm10184233.

Article  PubMed  PubMed Central  Google Scholar 

Li N, Ming X, Li Z. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;302(5):1063–74. https://doi.org/10.1007/s00404-020-05716-x.

Article  PubMed  Google Scholar 

Sahin H, Akdogan AI, Smith J, Zawaideh JP, Addley H. Serous borderline ovarian tumours: an extensive review on MR imaging features. Br J Radiol. 2021;94(1125):20210116. https://doi.org/10.1259/bjr.20210116.

Article  PubMed  PubMed Central  Google Scholar 

Ilenkovan N, Ryan N, Roxburgh P, Bell S, Gourley C. Controversies in the management of serous borderline tumors and low-grade serous ovarian cancer. IJGC. 2025;35(3):101673. https://doi.org/10.1016/j.ijgc.2025.101673.

Article  PubMed  Google Scholar 

Munakata S, Yamamoto T. Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan. Int J Gynecol Pathol. 2015;34(1):9–18. https://doi.org/10.1097/PGP.0000000000000108. Erratum in: Int J Gynecol Pathol. 2015 Mar.34(2):213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vang R, Shih IM. Serous tubal intra-epithelial carcinoma: what do we really know at this point? Histopathology. 2022;81(5):542–55. https://doi.org/10.1111/his.14722.

Article  PubMed  Google Scholar 

van den Berg CB, Dasgupta S, Ewing-Graham PC, Bart J, Bulten J, Gaarenstroom KN, de Hullu JA, Mom CH, Mourits MJE, Steenbeek MP, van Marion R, van Beekhuizen HJ. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2024;187:113–9. https://doi.org/10.1016/j.ygyno.2024.05.010.

Article  CAS  PubMed  Google Scholar 

Byun JM, Cho HJ, Lee DS, Yoon HK, Kim YN, Im DH, Kim DH, Lee KB, Sung MS, Jeong DH. Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer. Taiwan J Obstet Gynecol. 2023;62(1):107–11. https://doi.org/10.1016/j.tjog.2022.09.006.

Article  PubMed  Google Scholar 

Chien YW, Wang Y, Huang P, Lawson BC, Kolin DL, Chui MH, Vang R, Numan TA, Soong TR, Wang BG, Smith SA, Chen CL, Stone R, Douville C, Wang TL, Shih IM. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions. Am J Surg Pathol. 2024;48(4):475–86. https://doi.org/10.1097/PAS.0000000000002187.

Article  PubMed  PubMed Central  Google Scholar 

Raad J, Rolland L, Grynberg M, Courbiere B, Mathieu d’Argent E. Tumeurs frontières de l’ovaire. Recommandations pour la pratique clinique du CNGOF – Fertilité [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility]. Gynecol Obstet Fertil Senol. 2020;48(3):330–6. https://doi.org/10.1016/j.gofs.2020.01.020. French.

Article  CAS  PubMed  Google Scholar 

Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470(2):125–42. https://doi.org/10.1007/s00428-016-2040-8.

Article  CAS  PubMed  Google Scholar 

Laury AR, Ning G, Quick CM, Bijron J, Parast MM, Betensky RA, Vargas SO, McKeon FD, Xian W, Nucci MR, Crum CP. Fallopian tube correlates of ovarian serous borderline tumors. Am J Surg Pathol. 2011;35(12):1759–65. https://doi.org/10.1097/PAS.0b013e318233b0f7.

Article  PubMed  PubMed Central  Google Scholar 

Sun Y, Xu J, Jia X. The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives. Cancer Manag Res. 2020;12:3651–9. https://doi.org/10.2147/CMAR.S250394.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baker-Rand H, Bolton J, Morgan RD, Edmondson R. Borderline ovarian tumours. TOG. 2025;27(4):321–31. https://doi.org/10.1111/tog.70007.

Article  Google Scholar 

Wisztorski M, Aboulouard S, Roussel L, Duhamel M, Saudemont P, Cardon T, Narducci F, Robin YM, Lemaire AS, Bertin D, Hajjaji N, Kobeissy F, Leblanc E, Fournier I, Salzet M. Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death Dis. 2023;14(9):644. https://doi.org/10.1038/s41419-023-06165-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bogaerts JMA, Steenbeek MP, van Bommel MHD, Bulten J, van der Laak JAWM, de Hullu JA, Simons M. Recommendations for diagnosing STIC: a systematic review and meta-analysis. Virchows Arch. 2022;480(4):725–37. https://doi.org/10.1007/s00428-021-03244-w.

Article  PubMed  Google Scholar 

Kuhn E, Kurman RJ, Soslow RA, Han G, Sehdev AS, Morin PJ, et al. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Am J Surg Pathol. 2012;36(12):1826–34. https://doi.org/10.1097/PAS.0b013e31825ec07a.

Article  PubMed  PubMed Central  Google Scholar 

Nabina L, Mutum R, Laishram RS, Persy H, Rainy R, Hussain SMA. A study of histomorphological features of fallopian tube and immunohistochemical stains for p53 & ki67 of the fimbrial end of fallopian tube. Indian J Pathol Oncol. 2024;11(3):256–63. https://doi.org/10.18231/j.ijpo.2024.057.

Article  CAS  Google Scholar 

Kyo S, Ishikawa N, Nakamura K, Nakayama K. The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies. Cancer Med. 2020;9(2):421–31. https://doi.org/10.1002/cam4.2725.

Article  CAS  PubMed  Google Scholar 

Tewari S, Misra V, Kumar V, Mishra RR, Yadav K, Paridhi, Sangma H. Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes. Indian J Pathol Microbiol. 2022;65(3):610–6. https://doi.org/10.4103/ijpm.ijpm_529_21.

Article  PubMed  Google Scholar 

Sabelli R, Tessier-Cloutier B, Fu L, Leung SOA, Zeng X, Ribeiro R, Mandilaras V, Gilbert L, Bernard L. The challenge of managing isolated STIC lesions: A single-center experience. Gynecol Oncol Rep. 2025;58:101716. https://doi.org/10.1016/j.gore.2025.101716.

Article  PubMed  PubMed Central  Google Scholar 

Luvero D, Angioli R, Notaro E, Plotti F, Terranova C, Angioli AM, Festa A, Stermasi A, Manco S, Diserio M, Montera R. Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery. Diagnostics (Basel). 2024;14(22):2577. https://doi.org/10.3390/diagnostics14222577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention (SGO. November 2013) [(accessed on 3 October 2024)]. Available online: https://www.sgo.org/resources/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention/

Chong GO, Park JY, Lee HJ. Incidental Serous Tubal Intraepithelial Carcinoma that Developed into Primary Peritoneal Serous Carcinoma in a Patient without BRCA Mutation. Am J Case Rep. 2020;21:e921146. https://doi.org/10.12659/AJCR.921146.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Duval AJ, Adli M, Matei D. Biology-driven therapy advances in high-grade serous ovarian cancer. J Clin Invest. 2024;134(1):e174013. https://doi.org/10.1172/JCI174013.

Article  CAS  PubMed  PubMed Central  Google Scholar